Overview

Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT

Status:
Unknown status
Trial end date:
2021-03-30
Target enrollment:
Participant gender:
Summary
This study is to explore the efficacy and safety of introduction of chidamide in PTCy based GVHD prophylaxis in patients undergoing allogeneic PBSCT.
Phase:
Phase 2
Details
Lead Sponsor:
Sichuan University
Treatments:
Cyclophosphamide
Cyclosporine
Cyclosporins